25 results on '"Unciti ‐ Broceta, Asier"'
Search Results
2. Supplementary Data from Loss of Integrin-Linked Kinase Sensitizes Breast Cancer to SRC Inhibitors
3. Supplementary Data from Loss of Integrin-Linked Kinase Sensitizes Breast Cancer to SRC Inhibitors
4. Supplementary Data from Loss of Integrin-Linked Kinase Sensitizes Breast Cancer to SRC Inhibitors
5. Supplementary Data from A Conformation Selective Mode of Inhibiting SRC Improves Drug Efficacy and Tolerability
6. Data from Loss of Integrin-Linked Kinase Sensitizes Breast Cancer to SRC Inhibitors
7. Supplementary Data from A Conformation Selective Mode of Inhibiting SRC Improves Drug Efficacy and Tolerability
8. Data from Loss of Integrin-Linked Kinase Sensitizes Breast Cancer to SRC Inhibitors
9. Supplementary Data from A Conformation Selective Mode of Inhibiting SRC Improves Drug Efficacy and Tolerability
10. Supplementary Data from Loss of Integrin-Linked Kinase Sensitizes Breast Cancer to SRC Inhibitors
11. Supplementary Data from A Conformation Selective Mode of Inhibiting SRC Improves Drug Efficacy and Tolerability
12. Supplementary Data from Loss of Integrin-Linked Kinase Sensitizes Breast Cancer to SRC Inhibitors
13. Data from A Conformation Selective Mode of Inhibiting SRC Improves Drug Efficacy and Tolerability
14. Supplementary Figure from Loss of Integrin-Linked Kinase Sensitizes Breast Cancer to SRC Inhibitors
15. Supplementary Data from Loss of Integrin-Linked Kinase Sensitizes Breast Cancer to SRC Inhibitors
16. Supplementary Data from Loss of Integrin-Linked Kinase Sensitizes Breast Cancer to SRC Inhibitors
17. Supplementary Data from Loss of Integrin-Linked Kinase Sensitizes Breast Cancer to SRC Inhibitors
18. Supplementary Data from A Conformation Selective Mode of Inhibiting SRC Improves Drug Efficacy and Tolerability
19. Supplementary Data from A Conformation Selective Mode of Inhibiting SRC Improves Drug Efficacy and Tolerability
20. Supplementary Data from Loss of Integrin-Linked Kinase Sensitizes Breast Cancer to SRC Inhibitors
21. Supplementary Data from Loss of Integrin-Linked Kinase Sensitizes Breast Cancer to SRC Inhibitors
22. Abstract 3326: Uncovering the molecular mechanisms which predict sensitivity to a novel src kinase inhibitor NXP900 to inform personalized healthcare strategies
23. Loss of Integrin-Linked Kinase Sensitizes Breast Cancer to SRC Inhibitors
24. A Conformation Selective Mode of Inhibiting SRC Improves Drug Efficacy and Tolerability
25. Abstract C25: Targeting cancer stem cells using ALDH-dependent 5-nitrofuran pro-drugs
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.